RBM47

Across TCGA pan-cancer cohorts, RBM47 RNA is linked to patient survival in 25 of 34 cancer types, making it the most broadly survival-associated RBM47 data layer compared with 5 for mutation status and 5 for mass-spec protein.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher RBM47 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated RBM47 expression acts as an unfavorable survival marker, although some lineages such as KIRC and SKCM show a favorable association.

KIRC, SKCM, and HNSC are the cancer types where RBM47 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	DFS	Median	All	0.746	0.499	<.001	184	view →
SKCM	OS	Median	All	0.403	0.262	<.001	62	view →
HNSC	DFS	Tertile	All	0.760	0.622	<.001	61	view →
LGG	DFS	Median	All	0.676	0.801	<.001	52	view →
KIRP	OS	Quartile	All	0.918	0.543	.006	38	view →
LIHC	DFS	Tertile	All	0.467	0.647	<.001	38	view →
MESO	OS	Quartile	All	0.714	0.392	.002	31	view →
COAD	DFS	Quartile	II,III,IV	0.800	0.566	.005	28	view →
UVM	DFS	Tertile	III,IV	0.191	1.000	.002	22	view →
ESCA	OS	Tertile	All	0.307	1.000	.004	22	view →
GBM	DFS	Tertile	All	0.162	0.429	<.001	21	view →
LAML	DFS	Quartile	All	0.495	0.886	.004	20	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 25 lineages.

RBM47–KIRC (DFS)

Open the KIRC breakdown →